Alphatica — $IONS down almost 17% this morning on failed trial news in partnership with Astrazenca. The data is below. You decide.
What was actually lost vs. what's intact:
Lost: The ATTR-…↗
Jul 9
Adam Feuerstein ✡️ — What a day for ATTR-CMians...
$AZN $IONS Wainua ouch. Thanks for playing. You're out.
$ALNY Amvuttra, the silencer stands alone. But wither nucresiran?
$BBIO Attruby sheds a co…↗
Jul 9
Adam Feuerstein ✡️ — AstraZeneca $AZN, Ionis $IONS report major trial failure with heart disease drug
Wainua fails in ATTR-CM, $ALNY + 16% $BBIO +12%
https://t.co/41qJuUo6Uv via @DrewQJoseph↗
June 2026 · 6 mentions
Jun 29
Alphatica — $IONS Updated quadrant call
🟢 Validated bullish regime, first day of confirmation
1. NET DP $ positive (+$19.55M) vs prior cumulative −$14M
2. A $2.90M uptick
3. The $79 ceilin…↗
Jun 26
Alphatica — Someone is thinking buyout on $IONS
$IONS $QQQ $XBI https://t.co/O0HBqqMRXL↗
Jun 26
Alphatica — $IONS up another ~4% this morning. Something cooking.
$IONS $XBI $SPY↗
Jun 25
Alphatica — $IONS update. Keep an eye on this one. They added the 80 Calls August exp aggressively today. In addition there were 3 price hikes today.
$XBI $QQQ
September 2025 · 1 mention
Sep 2
Adam Feuerstein ✡️ — Ionis $IONS drug lowers triglycerides, reduces pancreas damage in late-stage studies https://t.co/hjtUMxw2Ip via @JonathanWosen↗
August 2025 · 1 mention
Aug 21
Adam Feuerstein ✡️ — FDA approves Ionis $IONS drug that prevents swelling attacks caused by a rare disease
Interesting: The Dawnzera label includes a warning for anaphylaxis, not mentioned in the NEJ…↗
Alphatica — We want to bring your attention to IONS.
IONS is a buyout candidate. Today's FDA approval just removed the last major binary risk.
Here is the thesis.
Ionis Pharmaceuticals is…↗
Jun 17
Alphatica — @The_WholeArmour $SRPT is up big today no? $IONS is up as well.↗